FDA Bioequivalence (BE) approval for the IVPT study conducted on Penciclovir Cream 1%
Diteba Inc. has received FDA Bioequivalence (BE) approval for the IVPT study conducted on Penciclovir Cream 1%. The IVPT method is an essential biowaiver tool for evaluating bioequivalence in generic dermal and transdermal products.
Read More “FDA Bioequivalence (BE) approval for the IVPT study conducted on Penciclovir Cream 1%”